Skip to main content Accessibility help
×
Home

Device-Associated Infection Rate and Mortality in Intensive Care Units of 9 Colombian Hospitals: Findings of the International Nosocomial Infection Control Consortium

  • Carlos Álvarez Moreno (a1) (a2), Victor D. Rosenthal (a3), Narda Olarte (a4), Wilmer Villamil Gomez (a5) (a6), Otto Sussmann (a7) (a8), Julio Garzon Agudelo (a9), Catherine Rojas (a10), Laline Osorio (a1), Claudia Linares (a2), Alberto Valderrama (a4), Patricia Garrido Mercado (a5), Patrick Hernán Arrieta Bernate (a5), Guillermo Ruiz Vergara (a6), Alberto Marrugo Pertuz (a6), Beatriz Eugenia Mojica (a7), María del Pilar Torres Navarrete (a8), Ana Sofia Alonso Romero (a11) and Daibeth Henríquez (a11)...

Abstract

Objective.

To perform active targeted prospective surveillance to measure device-associated infection (DAI) rates, attributable mortality due to DAI, and the microbiological and antibiotic resistance profiles of infecting pathogens at 10 intensive care units (ICUs) in 9 hospitals in Colombia, all of which are members of the International Infection Control Consortium.

Methods.

We conducted prospective surveillance of healthcare-associated infection in 9 hospitals by using the definitions of the US Centers for Disease Control and Prevention National Nosocomial Surveillance System (NNIS). DAI rates were calculated as the number of infections per 100 ICU patients and per 1,000 device-days.

Results.

During the 3-year study, 2,172 patients hospitalized in an ICU for an aggregate duration of 14,603 days acquired 266 DAIs, for an overall DAI rate of 12.2%, or 18.2 DAIs per 1,000 patient-days. Central venous catheter (CVC)–related bloodstream infection (BSI) (47.4% of DAIs; 11.3 cases per 1,000 catheter-days) was the most common DAI, followed by ventilator-associated pneumonia (VAP) (32.3% of DAIs; 10.0 cases per 1,000 ventilator-days) and catheter-associated urinary tract infection (CAUTI) (20.3% of DAIs; 4.3 cases per 1,000 catheter-days). Overall, 65.4% of all Staphylococcus aureus infections were caused by methicillin-resistant strains; 40.0% of Enterobacteriaceae isolates were resistant to ceftriaxone and 28.3% were resistant to ceftazidime; and 40.0% of Pseudomonas aeruginosa isolates were resistant to fluoroquinolones, 50.0% were resistant to ceftazidime, 33.3% were resistant to piperacillin-tazobactam, and 19.0% were resistant to imipenem. The crude unadjusted attributable mortality was 16.9% among patients with VAP (relative risk [RR], 1.93; 95% confidence interval [CI], 1.24-3.00; P = .002); 18.5 among those with CVC-associated BSI (RR, 2.02; 95% CI, 1.42-2.87; P<.001); and 10.5% among those with CAUTI (RR, 1.58; 95% CI, 0.78-3.18; P = .19).

Conclusion.

The rates of DAI in the Colombian ICUs were lower than those published in some reports from other Latin American countries and were higher than those reported in US ICUs by the NNIS. These data show the need for more-effective infection control interventions in Colombia.

Copyright

Corresponding author

Medical Institute of General Hygiene and Environmental Health, University of Goettingen, Windausweg 2, D-37073 Goettingen, Germany (hdunkell@gwdg.de)

References

Hide All
1.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470485.
2.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am J Cardiol 1998; 82:789793.
3.Hughes, JM. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy 1988; 34:553561.
4.Reed, CS, Gorrie, G, Spelman, D. Hospital infection control in Australia. J Hosp Infect 2003; 54:267271.
5.Cook, DJ, Walter, SD, Cook, RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433440.
6.Gastmeier, P, Hentschel, J, de Veer, I, Obladen, M, Ruden, H. Device-associated nosocomial infection surveillance in neonatal intensive care using specified criteria for neonates. J Hosp Infect 1998; 38:5160.
7.Jarvis, WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17:552557.
8.Fagon, JY, Chastre, J, Vuagnat, A, Trouillet, JL, Novara, A, Gibert, C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866869.
9.Digiovine, B, Chenoweth, C, Watts, C, Higgins, M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976981.
10.Tambyah, PA, Knasinski, V, Maki, DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002; 23:2731.
11.Fagon, JY, Novara, A, Stephan, F, Girou, E, Safar, M. Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 1994; 15:428434.
12.Emori, TG, Culver, DH, Horan, TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991; 19:1935.
13.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128140.
14.Vincent, JL, Bihari, DJ, Suter, PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639644.
15.Pittet, D, Thievent, B, Wenzel, R, Li, N, Auckenthaler, R, Suter, P. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153:684693.
16.Safdar, N, Crnich, CJ, Maki, DG. Nosocomial infections in the intensive care unit associated with invasive medical devices. Curr Infect Dis Rep 2001; 3:487495.
17.Diener, JR, Coutinho, MS, Zoccoli, CM. Central venous catheter-related infections in critically ill patients. Rev Assoc Med Bras 1996; 42:205214.
18.Velasco, E, Thuler, LC, Martins, CA, Dias, LM, Goncalves, VM. Nosocomial infections in an oncology intensive care unit. Am J Infect Control 1997; 25:458462.
19.Mittal, N, Nair, D, Gupta, N, et al. Outbreak of Acinetobacter spp septicemia in a neonatal ICU. Southeast Asian J Trop Med Public Health 2003; 34:365366.
20.Villanova, P. Minimum Inhibitory Concentration Interpretive Standards. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997. Document M7-A4.
21.Villamil Gómez, W, Ruíz Vergara, G, Marrugo Pertuz, A, Rosenthal, VD. Education and performance feedback effect on rates of central vascular catheter–associated bloodstream infections in new born intensive care units in a private hospital of Sucre, Colombia. In: Program and abstracts of the Association for Professional in Infection Control and Epidemiology 2005 Annual Conference; June 19-23, 2005; Baltimore, MD. Abstract 51829.
22.Freeman, R. Predictors for infection following open-heart surgery. J Hosp Infect 1991;18(Suppl):299307.
23.Maki, DG, Weise, CE, Sarafin, HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296:13051309.
24.Higuera, F, Rosenthal, VD, Duarte, P, Ruiz, J, Franco, G, Safdar, N. The effect of process control on the incidence of central venous catheter–associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med 2005; 33:20222027.
25.Pittet, D. Nosocomial pneumonia: incidence, morbidity and mortality in the intubated-ventilated patient. Schweiz Med Wochenschr 1994; 124:227235.
26.Rosenthal, VD, Guzman, S, Migone, O, Crnich, CJ. The attributable cost, length of hospital stay, and mortality of central line–associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003; 31:475480.
27.Rosenthal, VD, Guzman, S, Orellano, PW, Safdar, N. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003; 31:291295.
28.Orsi, GB, Di Stefano, L, Noah, N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002; 23:190197.
29.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:15981601.
30.Rosenthal, VD, Guzman, S, Migone, O, Safdar, N. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control 2005; 33:157161.
31.Francisco Higuera, MR-F, Rosenthal, VD, Castanon, J, et al. The attributable cost, and length of hospital stay of central line–associated blood stream infection in intensive care units in Mexico: a prospective, matched analysis. In: Program and abstracts of the 15th Annual Society for Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA; 2005. Abstract 170.
32.Lopes, JM, Tonelli, E, Lamounier, JA, et al. Prospective surveillance applying the national nosocomial infection surveillance methods in a Brazilian pediatric public hospital. Am J Infect Control 2002; 30:17.
33.Martinez-Aguilar, G, Anaya-Arriaga, MC, Avila-Figueroa, C. Incidence of nosocomial bacteremia and pneumonia in pediatric unit. Salud Publica Mex 2001; 43:515523.
34.Rezende, EM, Couto, BR, Starling, CE, Modena, CM. Prevalence of nosocomial infections in general hospitals in Belo Horizonte. Infect Control Hosp Epidemiol 1998; 19:872876.
35.Tinoco, JC, Salvador-Moysen, J, Perez-Prado, MC, Santillan-Martinez, G, Salcido-Gutierrez, L. Epidemiology of nosocomial infections in a second level hospital. Salud Publica Mex 1997; 39:2531.
36.Fridkin, SK, Pear, SM, Williamson, TH, Galgiani, JN, Jarvis, WR. The role of understaffing in central venous catheter–associated bloodstream infections. Infect Control Hosp Epidemiol 1996; 17:150158.
37.Archibald, LK, Manning, ML, Bell, LM, Banerjee, S, Jarvis, WR. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric cardiac intensive care unit. Pediatr Infect Dis J 1997; 16:10451048.
38.Harbarth, S, Sudre, P, Dharan, S, Cadenas, M, Pittet, D. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999; 20:598603.
39.Hugonnet, S, Harbarth, S, Sax, H, Duncan, RA, Pittet, D. Nursing resources: a major determinant of nosocomial infection? Curr Opin Infect Dis 2004; 17:329333.
40.Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997;46(RR-1):179.
41.O'Grady, NP, Alexander, M, Dellinger, EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30:476489.
42.Boyce, JM, Pittet, D. Guideline for hand hygiene in health-care settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 2002; 30:146.
43.Rosenthal, VD, Guzman, S, Safdar, N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005; 33:392397.
44.Rosenthal, VD, Guzman, S, Pezzotto, SM, Crnich, CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device–associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003; 31:405409.
45.Rosenthal, VD, McCormick, RD, Guzman, S, Villamayor, C, Orellano, PW. Effect of education and performance feedback on handwashing: the benefit of administrative support in Argentinean hospitals. Am J Infect Control 2003;31:8592.
46.Rosenthal, VD, Maki, DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter–associated bacteremia. Am J Infect Control 2004; 32:135141.
47.Rosenthal, VD, Guzman, S, Safdar, N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol 2004; 25:4750.
48.Rosenthal, VD, Guzman, S, Crnich, C. Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals. Am J Infect Control 2006; 34:5863.
49.Sobreyra Oropeza, M, Herrera Bravo, M, Rosenthal, VD. Nosocomial Infection global rates and central vascular catheter–associated bloodstream infections rates reduction in a new born intensive care unit of one Mexican public hospital. In: Program and abstracts of the 15th Annual Society for Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA; 2005. Abstract 254.
50.Salomao, R, Blecher, S, Maretti da Silva, MA, Vilins, M, Hilärio da Silva, E, Rosenthal, VD. Education and performance feedback effect on rates of central vascular catheter–associated bloodstream infections in adult intensive care units of one Brazilian hospital of Sao Paulo. In: Program and abstracts of the Association for Professional in Infection Control and Epidemiology 2005 Annual Conference; June 19-23,2005; Baltimore, MD. Abstract 51803.
51.Kurlat, I, Corral, G, Oliveira, F, Farinella, G, Alvarez, E. Infection control strategies in a neonatal intensive care unit in Argentina. J Hosp Infect 1998; 40:149154.
52.Berg, DE, Hershow, RC, Ramirez, CA, Weinstein, RA. Control of nosocomial infections in an intensive care unit in Guatemala City. Clin Infect Dis 1995; 21:588593.
53.Arias, CA, Reyes, J, Zuniga, M, et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 2003; 51:5968.
54.Lemeshow, S, Le Gall, JR. Modeling the severity of illness of ICU patients: a systems update. JAMA 1994; 272:10491055.
55.Safdar, N, Maki, DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834844.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed